124 related articles for article (PubMed ID: 34999591)
21. Gastric adenocarcinoma of fundic gland type spreading to heterotopic gastric glands.
Manabe S; Mukaisho KI; Yasuoka T; Usui F; Matsuyama T; Hirata I; Boku Y; Takahashi S
World J Gastroenterol; 2017 Oct; 23(38):7047-7053. PubMed ID: 29097877
[TBL] [Abstract][Full Text] [Related]
22. Gastric adenocarcinoma of fundic gland type with signet-ring cell carcinoma component: A case report and review of the literature.
Kai K; Satake M; Tokunaga O
World J Gastroenterol; 2018 Jul; 24(26):2915-2920. PubMed ID: 30018486
[TBL] [Abstract][Full Text] [Related]
23. Gastric adenocarcinoma of the fundic gland type: clinicopathological features of eight patients treated with endoscopic submucosal dissection.
Li C; Wu X; Yang S; Yang X; Yao J; Zheng H
Diagn Pathol; 2020 Oct; 15(1):131. PubMed ID: 33097069
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological features of early stage gastric adenocarcinoma of fundic gland type: Case series.
Zhang H; Wang S; Zhang Y; Ye F; Wang C
Medicine (Baltimore); 2022 Jan; 101(2):e28469. PubMed ID: 35029193
[TBL] [Abstract][Full Text] [Related]
25. Pepsinogens I and II in carcinoma of the stomach: an immunohistochemical study.
Stemmermann GN; Samloff IM; Hayashi T
Appl Pathol; 1985; 3(3):159-63. PubMed ID: 3915949
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological features of early gastric cancers arising in
Sato C; Hirasawa K; Tateishi Y; Ozeki Y; Sawada A; Ikeda R; Fukuchi T; Nishio M; Kobayashi R; Makazu M; Kaneko H; Inayama Y; Maeda S
World J Gastroenterol; 2020 May; 26(20):2618-2631. PubMed ID: 32523315
[TBL] [Abstract][Full Text] [Related]
27. Gastric adenocarcinoma of the fundic gland (chief cell-predominant type): A review of endoscopic and clinicopathological features.
Miyazawa M; Matsuda M; Yano M; Hara Y; Arihara F; Horita Y; Matsuda K; Sakai A; Noda Y
World J Gastroenterol; 2016 Dec; 22(48):10523-10531. PubMed ID: 28082804
[TBL] [Abstract][Full Text] [Related]
28. Endoscopic features of oxyntic gland adenoma and gastric adenocarcinoma of the fundic gland type differ between patients with and without Helicobacter pylori infection: a retrospective observational study.
Iwamuro M; Kusumoto C; Nakagawa M; Matsueda K; Kobayashi S; Yoshioka M; Inaba T; Toyokawa T; Sakaguchi C; Tanaka S; Tanaka T; Okada H
BMC Gastroenterol; 2022 Jun; 22(1):294. PubMed ID: 35692036
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological features of gastric adenocarcinoma of the fundic gland (chief cell predominant type) by retrospective and prospective analyses of endoscopic findings.
Chiba T; Kato K; Masuda T; Ohara S; Iwama N; Shimada T; Shibuya D
Dig Endosc; 2016 Nov; 28(7):722-730. PubMed ID: 27129734
[TBL] [Abstract][Full Text] [Related]
30. Gastric Adenocarcinoma of the Fundic Gland Type after Endoscopic Therapy for Metachronous Gastric Cancer.
Kino H; Nakano M; Kanamori A; Suzuki T; Kaneko Y; Tsuchida C; Tsuchida K; Tominaga K; Sasai T; Yamagishi H; Imai Y; Hiraishi H
Intern Med; 2018 Mar; 57(6):795-800. PubMed ID: 29225256
[TBL] [Abstract][Full Text] [Related]
31. Ontogeny of the stomach in yellow catfish (Pelteobagrus fulvidraco): detection and quantifictation of pepsinogen and H+/K+ -ATPase gene expression.
Gao C; Yang RB; Hu WB; Wang J
J Anim Physiol Anim Nutr (Berl); 2013 Feb; 97(1):20-6. PubMed ID: 22011269
[TBL] [Abstract][Full Text] [Related]
32. Helicobacter pylori infection-negative gastric cancer in Japanese hospital patients: incidence and pathological characteristics.
Kato S; Matsukura N; Tsukada K; Matsuda N; Mizoshita T; Tsukamoto T; Tatematsu M; Sugisaki Y; Naito Z; Tajiri T
Cancer Sci; 2007 Jun; 98(6):790-4. PubMed ID: 17470129
[TBL] [Abstract][Full Text] [Related]
33. Gastric Adenocarcinoma of the Fundic Gland Type: Update and Literature Review.
Benedict MA; Lauwers GY; Jain D
Am J Clin Pathol; 2018 Apr; 149(6):461-473. PubMed ID: 29648578
[TBL] [Abstract][Full Text] [Related]
34. Benign gastric polyps: morphological and functional origin.
Borch K; Skarsgård J; Franzén L; Mårdh S; Rehfeld JF
Dig Dis Sci; 2003 Jul; 48(7):1292-7. PubMed ID: 12870785
[TBL] [Abstract][Full Text] [Related]
35. The expression of gastric H+-K+-ATPase mRNA and protein in developing rat fundic gland.
Yang DH; Tsuyama S; Murata F
Histochem J; 2001 Mar; 33(3):159-66. PubMed ID: 11508339
[TBL] [Abstract][Full Text] [Related]
36. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
Suzuki H; Masaoka T; Hosoda H; Nomura S; Ohara T; Kangawa K; Ishii H; Hibi T
Hepatogastroenterology; 2004; 51(59):1249-54. PubMed ID: 15362725
[TBL] [Abstract][Full Text] [Related]
37. Gastric adenocarcinoma of fundic gland type: Endoscopic and clinicopathological features.
Tohda G; Osawa T; Asada Y; Dochin M; Terahata S
World J Gastrointest Endosc; 2016 Feb; 8(4):244-51. PubMed ID: 26962407
[TBL] [Abstract][Full Text] [Related]
38. Gastric adenocarcinoma of fundic gland (chief cell predominant type) coexisting with well differentiated intestinal adenocarcinoma: A case report.
Liu L; Han L; Ma Q; Zhang J
Medicine (Baltimore); 2021 May; 100(21):e25861. PubMed ID: 34032698
[TBL] [Abstract][Full Text] [Related]
39. [A case of gastric-type adenoma with chief cell and parietal cell differentiation surrounded by complete intestinal metaplasia].
Furukawa R; Oyama T; Takahashi A; Yorimitsu N; Shimoda T; Ota H; Shiozawa S
Nihon Shokakibyo Gakkai Zasshi; 2017; 114(3):450-455. PubMed ID: 28260713
[TBL] [Abstract][Full Text] [Related]
40. Pepsinogens I and II in gastric cancer: an immunohistochemical study using monoclonal antibodies.
Huang SC; Miki K; Sano J; Ichinose M; Kawamura N; Oka H; Hirano K; Furihata C; Masugi Y; Takahashi K
Jpn J Cancer Res; 1988 Oct; 79(10):1139-46. PubMed ID: 3143702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
